Risk of lymphoma in patients with RA treated with anti-TNFalpha agents

Ann Rheum Dis. 2005 May;64(5):657-8. doi: 10.1136/ard.2005.035311.
No abstract available

Publication types

  • Comment
  • Review

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Humans
  • Immunologic Factors / adverse effects*
  • Lymphoma / chemically induced*
  • Risk Assessment
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Immunologic Factors
  • Tumor Necrosis Factor-alpha